These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10261467)

  • 1. Pharmaceutical Reimbursement Board; rinal maximum allowable cost (MAC) determinations for certain drug products--HCFA. Final notice for maximum allowable cost determinations.
    Fed Regist; 1982 Jun; 47(124):27968-73. PubMed ID: 10261467
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical Reimbursement Board; maximum allowable cost (MAC) limits and announcement of public hearing--HCFA. Proposed notice.
    Fed Regist; 1982 May; 47(104):23570-2. PubMed ID: 10261465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Reimbursement Board; final maximum allowable cost (MAC) determinations for certain drug products--Health Care Financing Administration. Final notice.
    Fed Regist; 1982 Dec; 47(251):58370-2. PubMed ID: 10259800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical Reimbursement Board; suspension of maximum allowable cost limits on specific drug products--HCFA.
    Fed Regist; 1983 Sep; 48(191):44931. PubMed ID: 10262646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations.
    Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicare and Medicaid programs, less than effective drugs. Health Care Financing Administration. Notice of legislation affecting implementation and enforcement of interim final rule.
    Fed Regist; 1982 Jan; 47(8):1386. PubMed ID: 10298360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare and Medicaid programs; limits on payments for drugs--HCFA. Final rule.
    Fed Regist; 1987 Jul; 52(147):28648-58. PubMed ID: 10301766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare program; outpatient prescription drugs: list of covered home i.v. drugs--HCFA. Proposed notice.
    Fed Regist; 1989 Sep; 54(172):37239-48. PubMed ID: 10303829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Privacy Act of 1974; system of records--HCFA. Notice of new system of records.
    Fed Regist; 1989 Aug; 54(160):34612-6. PubMed ID: 10303751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare program; Provider Reimbursement Review Board jurisdiction over challenge to apportionment of malpractice insurance costs--HCFA. Notice of HCFA ruling.
    Fed Regist; 1987 Apr; 52(80):13874-5. PubMed ID: 10301485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare program; Provider Reimbursement Review Board decision on the lack of jurisdiction--Health Care Financing Administration. Notice of HCFA ruling.
    Fed Regist; 1982 Dec; 47(232):54302-5. PubMed ID: 10298953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare program; provider reimbursement determinations and appeals. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 May; 73(101):30189-267. PubMed ID: 18605405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare and Medicaid programs; schedules of guidelines for physical therapy and respiratory therapy services--HCFA. Final notice.
    Fed Regist; 1983 Sep; 48(191):44922-30. PubMed ID: 10299246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare program; coverage of home intravenous drug therapy services--HCFA. Proposed rule.
    Fed Regist; 1989 Sep; 54(172):37422-38. PubMed ID: 10303831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare program; annual update to reasonable compensation equivalent limits for services furnished by physicians to providers--HCFA. Final notice with comment period.
    Fed Regist; 1985 Feb; 50(34):7123-31. PubMed ID: 10299897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HHS issues final regulation on Medicare-endorsed Prescription Drug Card Initiative.
    Health Care Law Mon; 2002 Sep; ():13-5. PubMed ID: 12420392
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicare program; Medicare-Endorsed Prescription Drug Card Assistance Initiative. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2002 Sep; 67(171):56617-85. PubMed ID: 12233763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10 initiatives may ensure uninterrupted drug coverage for dual eligibles.
    Med Health; 2005 Dec; 59(45):2. PubMed ID: 16372742
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.